All drugs.

Search drugs by brand or generic name, or refine the directory by prescription status, class, indication, manufacturer, and specialty.

Advertisement

Enter at least 3 characters to search the full directory.

Results

Showing 1–5 of 5 drugs · filtered

IBRANCE (palbociclib)

ANTINEOPLASTIC- CYCLIN-DEPENDENT KINASE (CDK) 4/6 INHIBITORS · HORMONE RECEPTOR (HR)-POSITIVE, HER2-NEGATIVE ADVANCED BREAST CANCER ·+2
Parke-Davis Pfizer

KISQALI (ribociclib succinate)

ANTINEOPLASTIC- CYCLIN-DEPENDENT KINASE (CDK) 4/6 INHIBITORS · HORMONE RECEPTOR (HR)-POSITIVE, HER2-NEGATIVE ADVANCED BREAST CANCER ·+1
Novartis Pharmaceuticals

VERZENIO (abemaciclib)

ANTINEOPLASTIC- CYCLIN-DEPENDENT KINASE (CDK) 4/6 INHIBITORS · HORMONE RECEPTOR (HR)-POSITIVE, HER2-NEGATIVE ADVANCED BREAST CANCER ·+2
Eli Lilly and Company

KISQALI (ribociclib succinate)

ANTINEOPLASTIC- CYCLIN-DEPENDENT KINASE (CDK) 4/6 INHIBITORS · HORMONE RECEPTOR (HR)-POSITIVE, HER2-NEGATIVE ADVANCED BREAST CANCER ·+1
Novartis Pharmaceuticals

COSELA (trilaciclib dihydrochloride)

ANTINEOPLASTIC- CYCLIN-DEPENDENT KINASE (CDK) 4/6 INHIBITORS · PREVENTION OF CHEMOTHERAPY-INDUCED MYELOSUPPRESSION IN EXTENSIVE-STAGE SMALL CELL LUNG CANCER
PHARMACOSMOS TH